2470
C. Wu et al. / Tetrahedron: Asymmetry 21 (2010) 2465–2470
J = 12.3, 5.4 Hz), 2.16–2.03 (m, 1H), 1.87–1.73 (m, 1H), 1.72–1.50
(m, 3H), 1.40–1.22 (m, 1H).
tR = 32.5 min (anti, major), tR = 34.7 min (anti, minor)). 1H NMR
(300 MHz, CDCl3): d 7.81–7.84 (m, 1H), 7.72–7.74 (m, 1H), 7.62 (m,
1H), 7.40–7.45 (m, 1H), 5.42 (d, 1H, J = 7.2 Hz), 3.95 (br, 1H),
2.89–2.92 (m, 1H), 2.44–2.46 (m, 1H), 2.33–2.39 (m, 2H), 2.09–
2.11 (m, 1H), 1.74–1.93 (m, 3H), 1.52 (m, 1H), 1.07 (d, J = 6.9 Hz, 3H).
4.3.19. (2S,10R)-2-(Hydroxy-(pyridin-4-yl)methyl) cyclohexan-
1-one 18
Yield 96%, anti/syn = 90:10, enantiomeric excess: 98% of anti-
diastereomer determined by HPLC (Dicael Chiralpak AD-H column;
i-PrOH/Hexane = 10:90; flow rate 1.0 mL/min, 20 °C, k = 254 nm;
tR = 27.5 min (anti, major), tR = 25.0 min (anti, minor)). 1H NMR
(300 MHz, CDCl3): d 8.53–8.55 (d, J = 6.0 Hz, 2H), 7.25–7.28 (d,
J = 6.0 Hz, 2H), 4.80 (d, J = 8.4 Hz, 1H), 4.29 (br, 1H), 2.31–2.63
(m, 3H), 2.07–2.12 (m, 1H), 1.81–1.84 (m, 1H), 1.61–1.71 (m,
4H), 1.30–1.41 (m, 1H).
4.3.25. (2S,4S)-2-((R)-Hydroxy(2-nitrophenyl)methyl)-4-methyl-
cyclohexan-1-one 24
Yield 97%, anti/syn = 96:4, enantiomeric excess: 95% of anti-dia-
stereomer determined by HPLC(Dicael Chiralpak AD-H column; i-
PrOH/Hexane = 10:90; flow rate 0.5 mL/min, 20 °C, k = 254 nm;
tR = 63.4 min (anti, major), tR = 46.5 min (anti, minor)). 1H NMR
(300 MHz, CDCl3): d 8.11 (s, 1H, Ar), 7.53–7.86 (m, 3H, Ar), 5.20
(d, 1H, J = 8.4 Hz), 3.93 (br, 1H), 2.85–2.90 (m, 1H), 2.45–2.47 (m,
1H), 2.35–2.42 (m, 2H), 2.38–2.79 (m, 2H), 1.90–1.93 (m, 1H),
1.64–1.75 (m, 3H), 1.43 (m, 1H), 1.06 (d, J = 6.9 Hz, 3H).
4.3.20. (2S,10R)-2-(Hydroxy-(4-nitrophenyl) methyl)-cyclo-
pentan-1-one 19
Yield 98%, anti/syn = 63:37, enantiomeric excess: 95% of anti-
isomer and 57% syn-isomer determined by HPLC (Dicael Chiralpak
AD-H column; i-PrOH/Hexane = 5:95; flow rate 1.0 mL/min, 20 °C,
k = 254 nm; tR = 58.4 min (anti, major), tR = 55.4 min (anti, minor));
tR = 30.8 min (syn, major), tR = 43.9 min (syn, minor)). 1H NMR
Acknowledgment
Authors are grateful to Southwest University of China for finan-
cial support.
(300 MHz, CDCl3):
d 8.21 (d, 2H, J = 8.7 Hz), 7.54 (d, 2H,
J = 9.0 Hz), 4.85 (d, 1H, J = 9.2 Hz), 4.76 (s, 1H), 2.54–2.18 (m, 3H),
References
2.08–1.95 (m, 1H), 1.81–1.48 (m, 3H).
1. (a) Dalko, P. I.; Moisan, L. Angew. Chem., Int. Ed. 2004, 116, 5248–5286; (b)
Berkssel, A.; Groger, H. In Asymmetric Organocatalysis; Wiley-VCH: Weinheim,
2005.
2. (a)For reviews on direct aldol reactions, see: Modern Aldol Additions; Mahrwald,
R., Ed.; Wiley-VCH: Weinheim, 2004; (b) Palomo, C.; Oiarbide, M.; Garcia, J. M.
Chem. Eur. J. 2002, 8, 36–44; (c) Machajewski, T. D.; Wong, C. H. Angew. Chem.,
Int. Ed. 2000, 39, 1352–1374.
4.3.21. (2S,10R)-2-(Hydroxy-(2-nitrophenyl) methyl)-cyclopen-
tan-1-one 20
Yield 96%, anti/syn = 52:48, enantiomeric excess: 99% of anti-
isomer and 81% syn-isomer determined by HPLC (Dicael Chiralpak
OD-H column; i-PrOH/Hexane = 5:95; flow rate 1.0 mL/min, 20 °C,
k = 254 nm; tR = 39.8 min (anti, major), tR = 43.2 min (anti, minor);
tR = 20.7 min (syn, major), tR = 23.1 min (syn, minor)). 1H NMR
(300 MHz, CDCl3): d 1.70–2.03 (m, 4H), 2.19–2.38 (m, 2H), 2.68
(d, J = 7.6 Hz, 1H), 2.90 (br, 1H), 5.21(d, J = 7.2 Hz, 1H), 7.44 (t,
J = 8.0 Hz, 1H, Ar–H), 7.66 (t, J = 8.0 Hz, 1H, Ar–H), 7.89 (d,
J = 8.0 Hz, 1H), 8.00 (dd, J = 8.0, 0.8 Hz, 1H).
3. For reviews, see: (a) Notz, W.; Tanaka, F.; Barbas, C. F., III Acc. Chem. Res. 2004,
37, 580–591; (b) Mukherjee, S.; Yang, J. W.; Hoffman, S.; List, B. Chem. Rev.
2007, 107, 5471–5569; (c) Liu, X. H.; Lin, L. L.; Feng, X. M. Chem. Commun. 2009,
41, 6145–6158; (d) Raj, M.; Singh, V. K. Chem. Commun. 2009, 42, 6687–6703;
(e) Xu, L. W.; Luo, J.; Lu, Y. X. Chem. Commun. 2009, 1807–1821; (f) Xu, L. W.; Lu,
Y. X. Org. Biomol. Chem. 2008, 6, 2047–2053; (g) Peng, F. Z.; Shao, Z. H. J. Mol.
Catal. A 2008, 285, 1–13; (h) Chen, Y. C. Synlett 2008, 1919–1930; (i) Bartoli, G.;
Melchiorre, P. Synlett 2008, 1759–1771; For selected examples of anti-aldol
reactions, see: (j) Casas, J.; Engqvist, M.; Ibrahem, I.; Kaynak, B.; Córdova, A.
Angew. Chem., Int. Ed. 2005, 44, 1343–1345; (k) Córdova, A.; Zou, W.; Ibrahem,
I.; Reyes, E.; Engqvist, M.; Liao, W. W. Chem. Commun. 2005, 3586–3588; (l)
Ibrahem, I.; Córdova, A. Tetrahedron Lett. 2005, 46, 3359–3363; (m) Torii, H.;
Nakadai, M.; Ishihara, K.; Saito, S.; Yamamoto, H. Angew. Chem., Int. Ed. 2004,
43, 1983–1986; (n) Mase, N.; Nakai, Y.; Ohara, N.; Yoda, H.; Takabe, K.; Tanaka,
F., ; Barbas, C. F., III J. Am. Chem. Soc. 2006, 128, 734–735; (o) Hayashi, Y.;
Sumiya, T.; Takahashi, J.; Gotoh, H.; Urushima, T.; Shoji, M. Angew. Chem., Int.
Ed. 2006, 45, 958–961; (p) Samanta, S.; Liu, J.; Dodda, R.; Zhao, C. G. Org. Lett.
2005, 7, 5321–5323; (q) Córdova, A.; Zou, W.; Dziedzic, P.; Ibrahem, I.; Reyes,
E.; Xu, Y. Chem. Eur. J. 2006, 12, 5383–5397; (r) Hayashi, Y.; Itoh, T.; Nagae, N.;
Ohkubo, M.; Ishikawa, H. Synlett 2008, 1565–1570.
4.3.22. (2S,10R)-2-(Hydroxy-(3-nitrophenyl) methyl)-cyclopen-
tan-1-one 21
Yield 98%, anti/syn = 75:25, enantiomeric excess: 98% of anti-
isomer and 31% syn-isomer determined by HPLC (Dicael Chiralpak
AD-H column; i-PrOH/Hexane = 8:92; flow rate 1.0 mL/min, 20 °C,
k = 254 nm; tR = 29.4 min (anti, major), tR = 43.3 min (anti, minor);
tR = 20.7 min (syn, major), tR = 23.1 min (syn, minor)). 1H NMR
(300 MHz, CDCl3): d 8.17–8.18 (m, 1H), 8.10 (ddd, J = 8.1, 2.3,
1.1 Hz, 1H), 7.62–7.65 (m, 1H), 7.47 (t, J = 7.9 Hz, 1H), 4.77 (d,
1H, J = 9.3 Hz), 4.72 (s, 1H), 2.16–2.47 (m, 3H), 1.92–2.01 (m, 1H),
1.61–1.78 (m, 2H), 1.50–1.55 (m, 1H).
4. (a)Organic Synthesis in Water; Grieco, P. A., Ed.; Blackie: London, 1998; (b)
Lindstrom, U. M. Chem. Rev. 2002, 102, 2751–2772; (c) Li, C. J. Chem. Rev. 2005,
105, 3095–3166; (d) Pirrung, M. C. Chem. Eur. J. 2006, 12, 1312–1317.
5. (a) Córdova, A.; Notz, W.; Barbas, C. F., III Chem. Commun. 2002, 3024–3025; (b)
Akthivel, K. S.; Notz, W.; Bui, T.; Barbas, C. F., III J. Am. Chem. Soc 2001, 123,
5260–5267.
6. (a) Monika, R.; Vinod, S. K. Chem. Commun. 2009, 44, 6687–6692; (b) Mase, N.;
Watanabe, K.; Yoda, H.; Takabe, K.; Tanaka, F.; Barbas, C. F., III J. Am. Chem. Soc.
2006, 128, 4966–4967; (c) Hayashi, Y.; Aratake, S.; Okano, T.; Takahashi, J.;
Sumiya, T.; Shoji, M. Angew. Chem., Int. Ed. 2006, 45, 5527–5529.
7. (a) Zhang, S. P.; Fu, X. K.; Fu, S. D.; Pan, J. F. Cat. Commun. 2009, 10, 401–405; (b)
Zhang, S. P.; Fu, X. K.; Fu, S. D. Tetrahedron Lett. 2009, 50, 1172–1173; (c) Fu, S.
D.; Fu, X. K.; Zhang, S. P.; Zou, X. C.; Wu, X. J. Tetrahedron: Asymmetry 2009, 20,
2390–2396.
8. Wu, X. Y.; Jiang, Z. Q.; Shen, H. M.; Lu, Y. X. Adv. Synth. Catal. 2007, 349, 812–
816.
9. For the use of hydrophobicity in organic synthesis, see: (a) Lindstrom, U. M.;
Andersson, F. Angew. Chem., Int. Ed. 2006, 45, 548–551; (b) Otto, S.; Engberts, J.
B. F. N. Org. Biomol. Chem. 2003, 1, 2809–2820; (c) Breslow, R. Acc. Chem. Res.
2004, 37, 471–478.
4.3.23. ((2S,4S)-2-((R)-Hydroxy(4-nitrophenyl)methyl)-4-meth-
ylcyclohexan-1-one 22
Yield 95%, anti/syn = 93:7, enantiomeric excess: 96% of anti-dia-
stereomer determined by HPLC (Dicael Chiralpak AD-H column; i-
PrOH/Hexane = 10:90; flow rate 1.0 mL/min, 20 °C, k = 254 nm;
tR = 36.3 min (anti, major), tR = 41.3 min (anti, minor)). 1H NMR
(300 MHz, CDCl3): d 8.18–8.23 (m, 2H), 7.47–7.52 (m, 2H), 4.92
(d, 1H, J = 8.6 Hz), 3.82 (br, 1H), 2.72–2.78 (m, 1H), 2.48–2.50 (m,
1H), 2.36–2.43 (m, 1H), 2.07–2.09 (m, 1H), 1.89–1.93 (m, 1H),
1.78–1.81 (m, 1H), 1.54–1.60 (m, 1H), 1.33 (m, 1H), 1.05 (d,
J = 6.9 Hz, 3H).
10. (a) Siyutkin, D. E.; Kucherenko, A. S.; Zlotin, S. G. Tetrahedron 2009, 65, 1366–
´
1372; (b) Dziedzic, P.; Ibrahem, I.; Cordova, A. Tetrahedron Lett. 2008, 49, 803–
4.3.24. (2S,4S)-2-((R)-Hydroxy(2-nitrophenyl)methyl)-4-methy-
lcyclohexan-1-one 23
Yield 98%, anti/syn = 99:1, enantiomeric excess: 99% of anti-dia-
stereomer determined by HPLC (Dicael Chiralpak AD-H column;
i-PrOH/Hexane = 10:90; flow rate 0.8 mL/min, 20 °C, k = 254 nm;
807; (c) Chen, L. L.; Han, X.; Huang, M. H.; Wong, M. W.; Lu, Y. X. Chem.
Commun. 2007, 40, 4143–4145; (d) Kristensen, T. E.; Hansen, F. K.; Hansen, T.
Eur. J. Org. Chem. 2009, 3, 387–395; (e) Kristensen, T. E.; Vestli, K.; Fredriksen, K.
A.; Hansen, F. K.; Hansen, T. Org. Lett. 2009, 11, 2968–2971.
11. (a) Kobayashi, S.; Manabe, K. Acc. Chem. Res. 2002, 35, 209–217; (b) Hamada, T.;
Manabe, K.; Kobayashi, S. J. Syn. Org. Chem. Jpn. 2003, 61, 445–448.